Microdialysis: an in vivo approach for measuring drug delivery in oncology
Martin Brunner1, Markus Müller
1Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, University of Vienna Medical School, Allgemeines Krankenhaus, Währinger Gürtel 18-20, 1090 Vienna, Austria. martin.brunner@univie.ac.at
Abstract:
Microdialysis (MD) is a catheter-based sampling method that provides the opportunity to directly study tumor drug exposure and metabolism in a minimally invasive way. Tumor drug exposure, which is directly linked to clinical outcome, may be substantially reduced due to diffusion barriers in solid tumors. Therefore plasma drug profiles are frequently inappropriate for predicting outcome in oncology. This contribution focuses on the application of MD in preclinical and clinical oncological research and presents an overview of the current literature. It is concluded that MD, in combination with pharmacokinetic/pharmacodynamic modeling, has the potential to contribute to the design of optimal treatment schedules and to select appropriate drug candidates, doses, and dosing intervals for established and new anticancer drugs.
Insights
Microdialysis (MD) offers direct tumor drug exposure insights, crucial for oncology outcomes. This method, combined with modeling, aids in optimizing anticancer drug selection and dosing schedules.
Area of Science:
- Oncology
- Pharmacology
- Biomedical Engineering
Background:
- Solid tumors present diffusion barriers, reducing drug exposure and impacting clinical outcomes.
- Plasma drug concentrations may not accurately predict treatment efficacy in cancer patients.
- Microdialysis (MD) is a minimally invasive technique for studying drug disposition within tumors.
Purpose of the Study:
- To review the application of microdialysis in preclinical and clinical oncological research.
- To highlight the importance of direct tumor drug exposure assessment.
- To explore the potential of MD in optimizing cancer therapy.
Main Methods:
- Literature review of microdialysis applications in oncology.
- Analysis of studies investigating tumor drug exposure and metabolism.
- Integration of microdialysis data with pharmacokinetic/pharmacodynamic modeling.
Main Results:
- Microdialysis enables direct measurement of drug concentrations within tumors.
- Tumor drug exposure can be significantly lower than predicted by plasma levels.
- MD provides valuable data for understanding drug penetration and efficacy.
Conclusions:
- Microdialysis is a valuable tool for assessing tumor drug exposure and metabolism.
- MD, coupled with PK/PD modeling, can guide the selection of optimal anticancer drugs, doses, and schedules.
- This approach has the potential to improve treatment strategies and patient outcomes in oncology.
Related Concept Videos
Drug Concentrations: Measurements
Plasma —...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Measurement of Bioavailability: Pharmacokinetic Methods
Measurement of Bioavailability: Pharmacodynamic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods


